26-Hydroxycholesterol

26-Hydroxycholesterol is a lipid of Sterol Lipids (ST) class. 26-hydroxycholesterol is associated with abnormalities such as Cardiovascular Diseases, Vascular Diseases, Metabolic syndrome, Obesity and Fatty Streak, Arterial. The involved functions are known as Oxidation, phospholipase activity, glucose metabolism, Binding (Molecular Function) and Regulation. 26-hydroxycholesterol often locates in Immune system, Body tissue, Extracellular, Protoplasm and Back. The associated genes with 26-Hydroxycholesterol are Homologous Gene, chylomicron remnant, Receptor Gene, Alleles and D3 compound. The related lipids are 27-hydroxycholesterol, Hydroxycholesterols, Lysophosphatidylcholines, Total cholesterol and Lipopolysaccharides. The related experimental models are Knock-out and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of 26-Hydroxycholesterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 26-Hydroxycholesterol?

26-Hydroxycholesterol is suspected in hypercholesterolemia, Obesity, Atherosclerosis, Metabolic syndrome, Neurodegenerative Disorders, Dyslipidemias and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 26-Hydroxycholesterol

MeSH term MeSH ID Detail
Inflammation D007249 119 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Alzheimer Disease D000544 76 associated lipids
Alcoholism D000437 27 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Xanthomatosis, Cerebrotendinous D019294 14 associated lipids
Total 7

PubChem Associated disorders and diseases

What pathways are associated with 26-Hydroxycholesterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 26-Hydroxycholesterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 26-Hydroxycholesterol?

Transgenic Model

Transgenic Model are used in the study 'Cholesterol and breast cancer pathophysiology.' (Nelson ER et al., 2014) and Transgenic Model are used in the study 'Obesity, cholesterol metabolism, and breast cancer pathogenesis.' (McDonnell DP et al., 2014).

Knock-out

Knock-out are used in the study 'The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha.' (Umetani M et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with 26-Hydroxycholesterol

Download all related citations
Per page 10 20 50 100 | Total 403
Authors Title Published Journal PubMed Link
Glöckner F et al. Dietary cholesterol and its effect on tau protein: a study in apolipoprotein E-deficient and P301L human tau mice. 2011 J. Neuropathol. Exp. Neurol. pmid:21412171
Gamba P et al. Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime. 2011 Aging Cell pmid:21272192
Karuna R et al. Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism. 2011 Atherosclerosis pmid:21130455
Iborra RT et al. Advanced glycation in macrophages induces intracellular accumulation of 7-ketocholesterol and total sterols by decreasing the expression of ABCA-1 and ABCG-1. 2011 Lipids Health Dis pmid:21957962
Jeitner TM et al. Oxysterol derivatives of cholesterol in neurodegenerative disorders. 2011 Curr. Med. Chem. pmid:21428891
Prasanthi JR et al. Silencing GADD153/CHOP gene expression protects against Alzheimer's disease-like pathology induced by 27-hydroxycholesterol in rabbit hippocampus. 2011 PLoS ONE pmid:22046282
Hong C et al. Constitutive activation of LXR in macrophages regulates metabolic and inflammatory gene expression: identification of ARL7 as a direct target. 2011 J. Lipid Res. pmid:21187453
Huwait EA et al. A novel role for c-Jun N-terminal kinase and phosphoinositide 3-kinase in the liver X receptor-mediated induction of macrophage gene expression. 2011 Cell. Signal. pmid:21070853
Lappano R et al. The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes. 2011 PLoS ONE pmid:21304949
Baker ME Insights from the structure of estrogen receptor into the evolution of estrogens: implications for endocrine disruption. 2011 Biochem. Pharmacol. pmid:21420388
Shafaati M et al. Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation. 2011 J. Lipid Res. pmid:21335619
Seet RC et al. Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress? 2011 Free Radic. Biol. Med. pmid:21420490
Mast N et al. Cholestenoic Acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain. 2011 Invest. Ophthalmol. Vis. Sci. pmid:20881306
Leoni V and Caccia C Oxysterols as biomarkers in neurodegenerative diseases. 2011 Chem. Phys. Lipids pmid:21515244
Liao WL et al. Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain. 2011 J. Proteome Res. pmid:21049985
Leoni V et al. Whole body cholesterol metabolism is impaired in Huntington's disease. 2011 Neurosci. Lett. pmid:21406216
Crosignani A et al. Oxysterols in bile acid metabolism. 2011 Clin. Chim. Acta pmid:21855537
Bełtowski J and Semczuk A Liver X receptor (LXR) and the reproductive system--a potential novel target for therapeutic intervention. 2010 Jan-Feb Pharmacol Rep pmid:20360612
Vallim T and Salter AM Regulation of hepatic gene expression by saturated fatty acids. 2010 Apr-Jun Prostaglandins Leukot. Essent. Fatty Acids pmid:20227267
Kölsch H et al. Alterations of cholesterol precursor levels in Alzheimer's disease. 2010 Biochim. Biophys. Acta pmid:20226877
Blom T et al. FTY720 stimulates 27-hydroxycholesterol production and confers atheroprotective effects in human primary macrophages. 2010 Circ. Res. pmid:20056921
Wang YM et al. The mechanism of dietary cholesterol effects on lipids metabolism in rats. 2010 Lipids Health Dis pmid:20070910
Dasari B et al. The oxysterol 27-hydroxycholesterol increases β-amyloid and oxidative stress in retinal pigment epithelial cells. 2010 BMC Ophthalmol pmid:20836858
Berrodin TJ et al. Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity. 2010 Mol. Pharmacol. pmid:20837678
Kumari U and Heese K Cardiovascular dementia - a different perspective. 2010 Open Biochem J pmid:20448820
Crow JA et al. Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids. 2010 Biochim. Biophys. Acta pmid:19761868
DuSell CD et al. The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis. 2010 Endocrinology pmid:20501668
Ullrich C et al. Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits. 2010 Mol. Cell. Neurosci. pmid:20696249
Marwarha G et al. Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices. 2010 J. Alzheimers Dis. pmid:20157255
Sniderman AD et al. Regulation of plasma LDL: the apoB paradigm. 2010 Clin. Sci. pmid:19922416
Jenner AM et al. The effect of APOE genotype on brain levels of oxysterols in young and old human APOE epsilon2, epsilon3 and epsilon4 knock-in mice. 2010 Neuroscience pmid:20416362
Taylor JM et al. Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI. 2010 Cardiovasc. Res. pmid:20083572
Weingärtner O et al. An alternative pathway of reverse cholesterol transport: the oxysterol 27-hydroxycholesterol. 2010 Atherosclerosis pmid:19801147
Seet RC et al. Oxidative damage in Parkinson disease: Measurement using accurate biomarkers. 2010 Free Radic. Biol. Med. pmid:19969070
Schüle R et al. Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis. 2010 J. Lipid Res. pmid:19812052
Crisafulli C et al. Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation. 2010 Respir. Res. pmid:20175894
Greenhill C Bone: High 27-hydroxycholesterol decreases BMD. 2010 Nat Rev Endocrinol pmid:20803803
Schneider H et al. A novel mutation in the sterol 27-hydroxylase gene of a woman with autosomal recessive cerebrotendinous xanthomatosis. 2010 Orphanet J Rare Dis pmid:20925952
Akram A et al. Increased expression of RXRα in dementia: an early harbinger for the cholesterol dyshomeostasis? 2010 Mol Neurodegener pmid:20843353
Seet RC et al. Markers of oxidative damage are not elevated in otherwise healthy individuals with the metabolic syndrome. 2010 Diabetes Care pmid:20185735
Grinberg LT and Thal DR Vascular pathology in the aged human brain. 2010 Acta Neuropathol. pmid:20155424
Riendeau V and Garenc C Effect of 27-hydroxycholesterol on survival and death of human macrophages and vascular smooth muscle cells. 2009 Free Radic. Res. pmid:19672739
Olkkonen VM and Hynynen R Interactions of oxysterols with membranes and proteins. 2009 Mol. Aspects Med. pmid:19248802
Gilardi F et al. Expression of sterol 27-hydroxylase in glial cells and its regulation by liver X receptor signaling. 2009 Neuroscience pmid:19665519
Lütjohann D et al. 4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo - effects of itraconazole in man. 2009 Int J Clin Pharmacol Ther pmid:19954708
Trousson A et al. Cross-talk between oxysterols and glucocorticoids: differential regulation of secreted phopholipase A2 and impact on oligodendrocyte death. 2009 PLoS ONE pmid:19956653
Solomon A et al. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. 2009 Neurosci. Lett. pmid:19560513
Morello F et al. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms. 2009 Atherosclerosis pmid:19426978
Björkhem I et al. Oxysterols and neurodegenerative diseases. 2009 Mol. Aspects Med. pmid:19248803
Seet RC et al. Oxidative damage in dengue fever. 2009 Free Radic. Biol. Med. pmid:19427377